Shell Asset Management CO Bionano Genomics, Inc. Transaction History

Shell Asset Management CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.06 - $1.97 $46 - $86	-44 Reduced 0.36%	12,262 $14,000
Q4 2022 Feb 07, 2023	SELL	$1.4 - $25.4 $1,173 - $21,285	-838 Reduced 6.38%	12,306 $18,000
Q3 2022 Nov 14, 2022	SELL	$0.36 - $36.0 $476 - $47,664	-1,324 Reduced 9.15%	13,144 $24,000
Q2 2022 Aug 09, 2022	BUY	$12.3 - $27.3 $947 - $2,102	77 Added 0.54%	14,468 $20,000
Q1 2022 May 04, 2022	SELL	$16.6 - $32.3 $37,499 - $72,965	-2,259 Reduced 13.57%	14,391 $37,000
Q4 2021 Feb 09, 2022	SELL	$29.9 - $61.2 $4,574 - $9,363	-153 Reduced 0.91%	16,650 $50,000
Q3 2021 Nov 04, 2021	SELL	$51.4 - $68.2 $34,438 - $45,694	-670 Reduced 3.83%	16,803 $92,000
Q2 2021 Aug 12, 2021	BUY	$44.1 - $84.0 $770,559 - $1.47 Million	17,473 New	17,473 $128,000

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $63.8M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.